Essex Investment Management Co Has Trimmed T2 Biosystems (TTOO) Stake; Teleflex (TFX) Had 6 Bullish Analysts

July 17, 2017 - By Linda Rogers

Essex Investment Management Co Llc decreased T2 Biosystems Inc (TTOO) stake by 67.04% reported in 2016Q4 SEC filing. Essex Investment Management Co Llc sold 159,916 shares as T2 Biosystems Inc (TTOO)’s stock declined 46.79%. The Essex Investment Management Co Llc holds 78,606 shares with $413,000 value, down from 238,522 last quarter. T2 Biosystems Inc now has $82.62M valuation. The stock rose 0.75% or $0.02 reaching $2.67. About 42,767 shares traded. T2 Biosystems Inc (NASDAQ:TTOO) has declined 60.66% since July 17, 2016 and is downtrending. It has underperformed by 77.36% the S&P500.

Among 7 analysts covering Teleflex (NYSE:TFX), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. Teleflex had 14 analyst reports since July 31, 2015 according to SRatingsIntel. Brean Capital maintained it with “Buy” rating and $157 target in Friday, March 11 report. The stock of Teleflex Incorporated (NYSE:TFX) has “Buy” rating given on Thursday, June 29 by Jefferies. As per Monday, June 26, the company rating was maintained by Barclays Capital. The stock has “Buy” rating by Jefferies on Friday, January 6. The company was upgraded on Wednesday, January 6 by Raymond James. On Thursday, April 28 the stock rating was maintained by Brean Capital with “Buy”. On Monday, November 30 the stock rating was initiated by Piper Jaffray with “Overweight”. The stock of Teleflex Incorporated (NYSE:TFX) earned “Hold” rating by Leerink Swann on Thursday, June 8. Needham initiated the shares of TFX in report on Tuesday, March 7 with “Buy” rating. The stock of Teleflex Incorporated (NYSE:TFX) has “Buy” rating given on Friday, February 26 by Brean Capital. See Teleflex Incorporated (NYSE:TFX) latest ratings:

29/06/2017 Broker: Jefferies Rating: Buy New Target: $230.0000 Maintain
08/06/2017 Broker: Leerink Swann Rating: Hold Maintain
26/06/2017 Broker: Barclays Capital Rating: Buy Maintain
07/03/2017 Broker: Needham Rating: Buy New Target: $221.00 Initiate

Analysts await T2 Biosystems Inc (NASDAQ:TTOO) to report earnings on August, 7. They expect $-0.49 earnings per share, up 15.52% or $0.09 from last year’s $-0.58 per share. After $-0.48 actual earnings per share reported by T2 Biosystems Inc for the previous quarter, Wall Street now forecasts 2.08% negative EPS growth.

Among 8 analysts covering T2 Biosystems Inc (NASDAQ:TTOO), 4 have Buy rating, 1 Sell and 3 Hold. Therefore 50% are positive. T2 Biosystems Inc had 14 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, August 2 by Canaccord Genuity. On Tuesday, April 12 the stock rating was downgraded by Janney Capital to “Neutral”. The firm has “Underweight” rating given on Wednesday, March 15 by Morgan Stanley. The company was upgraded on Wednesday, July 20 by WBB Securities. The stock of T2 Biosystems Inc (NASDAQ:TTOO) earned “Hold” rating by BTIG Research on Sunday, August 16. BTIG Research initiated T2 Biosystems Inc (NASDAQ:TTOO) on Tuesday, July 21 with “Neutral” rating. On Thursday, November 10 the stock rating was reinitiated by Leerink Swann with “Market Perform”. As per Thursday, September 3, the company rating was upgraded by BTIG Research. The stock of T2 Biosystems Inc (NASDAQ:TTOO) has “Buy” rating given on Wednesday, November 2 by Cantor Fitzgerald. The stock of T2 Biosystems Inc (NASDAQ:TTOO) has “Buy” rating given on Tuesday, October 27 by Canaccord Genuity.

Essex Investment Management Co Llc increased Zeltiq Aesthetics Inc (NASDAQ:ZLTQ) stake by 19,719 shares to 47,588 valued at $2.07 million in 2016Q4. It also upped Check Point Software Tech Lt (NASDAQ:CHKP) stake by 4,891 shares and now owns 8,420 shares. Eagle Pharmaceuticals Inc (NASDAQ:EGRX) was raised too.

Since May 9, 2017, it had 0 insider purchases, and 4 selling transactions for $2.00 million activity. 200 Teleflex Incorporated (NYSE:TFX) shares with value of $39,986 were sold by Klasko Stephen K. M.D.. Another trade for 2,246 shares valued at $435,892 was made by Deren John on Tuesday, May 9. $514,173 worth of Teleflex Incorporated (NYSE:TFX) was sold by RANDLE STUART A.

Investors sentiment decreased to 1.03 in Q4 2016. Its down 0.17, from 1.2 in 2016Q3. It is negative, as 60 investors sold Teleflex Incorporated shares while 106 reduced holdings. 50 funds opened positions while 121 raised stakes. 41.47 million shares or 2.40% more from 40.50 million shares in 2016Q3 were reported. Oakbrook Invs Ltd Liability Corporation reported 0.02% in Teleflex Incorporated (NYSE:TFX). Ironbridge Mgmt Ltd Partnership reported 60,785 shares or 0.44% of all its holdings. 4,012 are held by Envestnet Asset Mngmt. First Republic Invest Management Incorporated, a California-based fund reported 2,561 shares. Nomura Asset Management Ltd accumulated 5,000 shares. Regentatlantic Ltd Liability Corporation reported 2,773 shares. 4,285 were reported by Horizon Kinetics Limited Liability Corporation. Qs Ltd Liability invested 0% of its portfolio in Teleflex Incorporated (NYSE:TFX). Qci Asset Mngmt has invested 0.01% in Teleflex Incorporated (NYSE:TFX). Moreover, Stone Run Capital Ltd Liability Corporation has 2.77% invested in Teleflex Incorporated (NYSE:TFX). Northwestern Mutual Wealth Mgmt invested in 263 shares. 2,400 are owned by Ellington Mgmt Grp Ltd Llc. Riverhead Mngmt Lc stated it has 0.05% of its portfolio in Teleflex Incorporated (NYSE:TFX). Rhumbline Advisers has 0.03% invested in Teleflex Incorporated (NYSE:TFX). New York State Teachers Retirement System owns 77,646 shares.

It is down 24.36% since July 17, 2016 and is uptrending. It has outperformed by 7.66% the S&P500.

Teleflex Incorporated is a provider of medical technology products. The company has market cap of $9.58 billion. The Firm designs, develops, makes and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. It has a 43.94 P/E ratio. The Firm operates through six divisions: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa ; Asia, and Original Equipment Manufacturer (OEM).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.